S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
3 Chinese stocks poised for rebound
4 stocks benefitting from NVIDIA's explosive growth
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
Critical asset just had biggest fall on record (Ad)
First it was Tyson stock, now this food company is set to rally
6 reasons to buy Teva Pharmaceuticals stock sooner than later

Arteris (AIP) Earnings Date, Estimates & Call Transcripts

$6.60
+0.01 (+0.15%)
(As of 02/26/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

AIP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AIP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arteris Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.99) EPS
Next Year EPS Consensus Estimate: ($0.66) EPS

AIP Earnings Date and Information

Arteris has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Arteris Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
11/7/2023Q3 2023($0.28)($0.22)+$0.06($0.21)$13.00 million$13.27 million
8/3/2023Q2 2023($0.22)($0.25)($0.03)($0.24)$13.50 million$14.73 million
5/4/2023Q1 2023($0.26)($0.25)+$0.01($0.24)$11.86 million$13.15 million
2/28/2023Q4 2022($0.18)($0.20)($0.02)($0.19)$11.35 million$11.20 million    
11/8/2022Q3 2022($0.24)($0.23)+$0.01($0.23)$11.65 million$12.60 million
8/9/2022Q2 2022($0.17)($0.18)($0.01)($0.18)$13.00 million$14.82 million      
5/10/2022Q1 2022($0.22)($0.22)-($0.22)$11.00 million$11.76 million
3/3/2022Q4 2021($0.32)($0.12)+$0.20($0.27)$10.60 million$11.43 million    
11/30/2021Q3 2021($0.27)($0.21)+$0.06($0.22)$9.07 million$8.96 million    












Arteris Earnings - Frequently Asked Questions

When is Arteris's earnings date?

Arteris has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on AIP's earnings history.

How much revenue does Arteris generate each year?

Arteris (NASDAQ:AIP) has a recorded annual revenue of $53.67 million.

How much profit does Arteris generate each year?

Arteris (NASDAQ:AIP) has a recorded net income of -$36.87 million. AIP has generated -$1.04 earnings per share over the last four quarters.

What is Arteris's EPS forecast for next year?

Arteris's earnings are expected to grow from ($0.99) per share to ($0.66) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AIP) was last updated on 2/27/2024 by MarketBeat.com Staff